NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 212 filers reported holding NPS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVEY CAPITAL MANAGEMENT INC | 424,175 | $12,695,000 | 5.06% |
Opaleye Management Inc. | 150,000 | $4,490,000 | 3.32% |
OAK RIDGE INVESTMENTS LLC | 2,795,331 | $83,664,000 | 2.10% |
SCHOLTZ & COMPANY, LLC | 60,350 | $1,806,000 | 1.94% |
SECTORAL ASSET MANAGEMENT INC | 1,408,729 | $42,163,000 | 1.73% |
First Light Asset Management, LLC | 79,099 | $2,367,000 | 1.68% |
FCG ADVISORS, LLC | 71,146 | $2,129,000 | 1.51% |
Rhenman & Partners Asset Management AB | 166,970 | $4,997,000 | 1.50% |
BENDER ROBERT & ASSOCIATES | 73,611 | $2,203,000 | 1.48% |
Eventide Asset Management | 283,900 | $8,497,000 | 1.32% |